Melanocyte count on leukotrichia in vitiligo using S100 protein immunohistochemistry before and after phototherapy: A case report

Authors

  • Putri Hendria Wardhani Department of Dermatology and Venereology, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, Indonesia
  • Cita Rosita Sigit Prakoeswa
  • M. Yulianto Listiawan
  • Linda Astari
  • Iskandar Zulkarnain
  • Dwi Murtiastutik
  • Trisniartami Setyaningrum

Keywords:

melanocyte, phototherapy, S100 protein, vitiligo

Abstract

Vitiligo is the most common depigmentation disease with complex pathogenesis that is not well understood and therapeutic outcomes are often unsatisfactory. Leukotrichia in vitiligo is often associated with poor prognosis for vitiligo treatment. Until now narrowband ultraviolet B (NB-UVB) is considered the most effective and safe treatment for vitiligo. Evaluation of therapy by looking at the amount of melanocytes that can be seen with S100 protein immunohistochemistry will become more objective and accurate. Melanocyte count in four non segmental vitiligo patient with leukotrichia were evaluated. The patient was given only NB-UVB therapy twice a week for eight times. Skin biopsy was done before and after therapies using immunohistochemistry staining. The number of S100 protein in vitiligo patients with leukotrichia after NB-UVB therapy increased. Leukotrichia is a poor indicator for treatment response in vitiligo, but this case report showed that leucotrichia did not contribute to the lack of response upon medical treatment. 

References

Birlea SA, Spritz RA, Norris DA. Vitiligo. Dalam: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Leffel DJ, editors. Fitzpatrick’s Dermatology General Medicine. 8th Ed. New York: McGraw Hill Co. 2013. p.792-803.

Kutlubay Z, Karakus O, Engin B, Serdaroglu S. Vitiligo as autoimun disease. J Turk Acad Dermatol 2012;6(2):126r1.

Alikhan MD, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: A comprehensive overview. J Am Acad Dermatol 2011;65:473-91.

Park HY, Yaar M. Biology of melanocytes. Dalam: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Leffel DJ, editors. Fitzpatrick’s Dermatology in General Medicine 8th Ed. New York: McGraw Hill Co. 2013. p.792-803.

Nybakken GE, Sargen M, Abraham R, Zhang PJ, Ming M, Xu X. MITF acurately highlight epidermal melanocytes in atypical intraepidermal melanocytic proliferations. Am J Dermatopathol 2013;35(1):25-9.

Bastonini E, Kovacs D, Picardo M. Skin pigmentation and pigmentary disorders: focus on epidermal/ dermal cross-talk. Ann Dermatol 2016;28(3):279-89.

Halawi A., Abbas O, Mahalingam M. S100 proteins and the skin: a review. JEADV 2013.1-10.

Listiawan MY, Rimadhani M, Sandhika W. Jumlah dan fungsi melanosit leukotrikia pada vitiligo berdasarkan pemeriksaan imunohistokimia S100 dan Microphtalmia Associated Transcription Factor (MITF). Berkala Ilmu Kesehatan Kulit dan Kelamin 2016;28(3):182-5.

Lee DY, Kim CR, Park JH, Lee JH. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment. Int J Dermatol 2011 Aug; 50(8):925-7.

Lee CH, Wu SB, Hong CH, Yu HS, Wei YH. Molecular mechanisms of UV-induced apoptosis and its effects on skin residential cells: the implication in UV-based phototherapy. Int. J. Mol. Sci 2013;14:6414-35.

Videira IFS, Magina S, Moura DFL. Mechanisms regulating melanogenesis. An Bras Dermatol 2013;88(1):76-83.

Downloads

Published

2020-09-30

How to Cite

1.
Wardhani PH, Prakoeswa CRS, Listiawan MY, Astari L, Zulkarnain I, Murtiastutik D, Setyaningrum T. Melanocyte count on leukotrichia in vitiligo using S100 protein immunohistochemistry before and after phototherapy: A case report. J Pak Assoc Dermatol [Internet]. 2020Sep.30 [cited 2024May18];30(2):355-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1398

Issue

Section

Case Reports

Most read articles by the same author(s)

1 2 > >>